Targeting synaptic plasticity in schizophrenia: insights from genomic studies

AW Mould, NA Hall, I Milosevic… - Trends in molecular …, 2021 - cell.com
Patients with schizophrenia experience cognitive dysfunction and negative symptoms that
do not respond to current drug treatments. Historical evidence is consistent with the …

Targeting synaptic plasticity in schizophrenia: insights from genomic studies

AW Mould, NA Hall, I Milosevic… - Trends in Molecular …, 2021 - Elsevier
HighlightsRecent genomic findings identify many hundreds of genomic loci that are
associated with schizophrenia.Consistent with data from the pregenomic era, genomic …

Targeting synaptic plasticity in schizophrenia: insights from genomic studies

AW Mould, NA Hall, I Milosevic… - Trends in molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Patients with schizophrenia experience cognitive dysfunction and negative symptoms that
do not respond to current drug treatments. Historical evidence is consistent with the …

Targeting synaptic plasticity in schizophrenia: insights from genomic studies.

AW Mould, NA Hall, I Milosevic… - Trends in Molecular …, 2021 - europepmc.org
Patients with schizophrenia experience cognitive dysfunction and negative symptoms that
do not respond to current drug treatments. Historical evidence is consistent with the …